Innovative Formulation and Evaluation of Betahistine Floating Tablets for Vertigo Management

Pharmaceutical sciences- Pharmaceutics

Authors

  • Pavan Kumar Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India.
  • Subhash PG Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India.
  • Hindustan Abdul Ahad Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India. https://orcid.org/0000-0001-5329-6878
  • Pawan Dhamala Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India
  • Suprith D Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India
  • Chrishmitha Sequeira Department of Pharmaceutics, R. R College of Pharmacy, Chikkabanavara, Bangalore-560090, Karnataka, India

DOI:

https://doi.org/10.22376/ijlpr.2024.14.3.P1-P14

Keywords:

Betahistine, Chitosan, Citric acid, Floating, Meniere’s disease, Tablets

Abstract

Floating tablets are designed to improve the effectiveness and consistency of medication delivery. These specializedoral drug delivery systems are engineered to float on the gastric fluid in the stomach for an extended period, ensuring prolongedgastric retention that leads to a slow and controlled drug release, ultimately enhancing its bioavailability and therapeutic efficacy.Meniere's disease comprises recurrent spontaneous rotatory vertigo spells that patients describe as a spinning or whirling feelingand sensorineural hearing loss (SNHL) accompanied by recruitment and tinnitus. This study aimed to create buoyant tabletscontaining Betahistine (BTH) for treating Meniere's disease, designed to float in fluids and discharge the drug gradually. Theapproach involved the utilization of HPMC K4M 100 and Chitosan in combination as agents for swelling. Gas generation wasfacilitated by sodium bicarbonate and citric acid, while lactose was incorporated as a bulking agent. Tablets were fabricated usingthe direct compression technique and subjected to various assessments, including thickness, hardness, weight consistency,friability, BTH content, swelling capacity, buoyancy, and BTH release patterns. Notably, FTIR analyses indicated the absence ofsignificant interactions between the BTH and its constituents. This comprehensive strategy underscores the potential of thesetablets as a reliable and enduring treatment choice for Meniere's disease. Among nine formulations, F5 displayed the least BTHdischarge (73.47±1.27% over 12 h), while F2 demonstrated the highest discharge (85.92±2.36% over 12 h). These findingshighlight formulation F5's potential for controlled BTH discharge, which could be beneficial in managing Meniere's diseasesymptoms. This thorough investigation contributes to optimizing the formulation to treat Meniere's disease with buoyant tabletsincorporating Betahistine efficiently.

References

Ravishankar K, Sunil GV, Reddy VR, Ramakrishna K, Reddy GN, Raju PN. Formulation and Evaluation of Ciprofloxacin Floating Tablets. Journal of Current Pharma Research. 2012 Jul 1;2(4):655.

Aulton ME, Taylor K, editors. Aulton's pharmaceutics: the design and manufacture of medicines. Elsevier Health Sciences; 2013.

Bijumol C, William H, Kurien J, Kurian T. Formulation and evaluation of floating tablets of theophylline. Hygeia Drugs Med. 2013;5(1):23-31.

Duy TP. Formulation and evaluation of low floating lag time metformin hydrochloride 500 mg sustained release floating tablet. Asian Journal of Pharmaceutics (AJP). 2016 Dec 21;10(04).

Hussain MN, Al Masum MA, Akhter S, Sharmin F, Reza MS. Formulation and evaluation of gastro retentive floating tablets of simvastatin using hydrophilic rate retardant. Bangladesh Pharmaceutical Journal. 2012 Nov 12;15(2):119-26.

EI A, DE E, TO U, NI S. Formulation and in-vitro evaluation of theophylline hydrochloride effervescent floating tablets: effect of polymer concentration on tablet Buoyancy. Int J Pharm Pharm Sci. 2020.

Shaik K, Ahad HA, Chinthaginjala H, Babafakruddin P, Lakunde J, Ksheerasagare T. Gas generating floating tablets: A quick literature review for the scholars.

Sarfaraz M, Reddy PK, Udupi RH, Doddayya H. Formulation and in-vitro evaluation of bilayer floating tablets of tramadol hydrochloride. International Journal of Drug Development and Research. 2012 Jul;4(3):335-47.

Chinthaginjala H, Barghav GC, Reddy CM, Pradeepkumar B, Ahad HA, Akbari BV, Dholakiya RB, Shiyani BG, Lodhiya DJ, Shastry CS. Formulation and in vitro evaluation of floating tablets of dicloxacillin sodium using different polymers. Journal of Young Pharmacists. 2019;11(3):247.

Chinthaginjala H, Ahad HA, Pradeepkumar B, Gandhi KS, Kalpana K, Pushpalatha G, Sumala K. Formulation and in vitro evaluation of gastroretentive ofloxacin floating tablets using natural polymers. Research Journal of Pharmacy and Technology. 2021;14(2):851-6.

Sharma N, Agarwal D, Gupta MK, Khinchi M. A comprehensive review on floating drug delivery system. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011 Apr;2(2):428-41.

Dinakaran SK, Kumar S, Banji D, Avasarala H, Rao V. Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl. Brazilian Journal of Pharmaceutical Sciences. 2011;47:545-53.

Gondard E, Anaclet C, Akaoka H, Guo RX, Zhang M, Buda C, Franco P, Kotani H, Lin JS. Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology. 2013 May;38(6):1015-31.

Sajjadi H, Paparella MM. Meniere's disease. The Lancet. 2008 Aug 2;372(9636):406-14.

Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of Ménière’s disease. Neuropsychiatric disease and treatment. 2007 Aug 1;3(4):429-40.

Young JC. True melting point determination. The Chemical Educator. 2013;18:203-8.

Khedr A, Sheha M. Stress degradation studies on betahistine and development of a validated stability-indicating assay method. Journal of Chromatography B. 2008 Jun 15;869(1-2):111-7.

Kumar A, Nanda S, Chomwal R. Spectrophotometric estimation of betahistine hydrochloride in tablet formulations. Journal of Pharmacy and Bioallied Sciences. 2010 Apr 1;2(2):121-3.

Sharma S, Ganjoo R, Saha SK, Kang N, Thakur A, Assad H, Kumar A. Investigation of inhibitive performance of Betahistine dihydrochloride on mild steel in 1 M HCl solution. Journal of Molecular Liquids. 2022 Feb 1;347:118383.

Harsha SS, Ahad HA, Haranath C, Dasari RR, Gowthami M, Varam NJ, Musa GB. Exfoliation technique of composing and depictions of clopidogrel bisulphate afloat microspheres. Journal of Evolution of Medical and Dental Sciences. 2020 Apr 6;9(14):1156-61.

Chinthaginjala H, Ahad HA, Bhargav E, Pradeepkumar B. Central composite design aided formulation development and optimization of clarythromycin extended-release tablets. Indian Journal of Pharmaceutical Education and Research. 2021 Apr 1;55(2):395-406.

Jwalapuram R, Ahad HA, Haranath C, Thadipatri R, Varshitha CV, Kumar YB. A desktop reference to the solubility enhancement of drugs with the aid of surfactants.(2020). Int. J. Life Sci. Pharma Res.;11(5):P11-16.

Ahmad S, Khan JA, Kausar TN, Mahnashi MH, Alasiri A, Alqahtani AA, Alqahtani TS, Walbi IA, Alshehri OM, Elnoubi OA, Mahmood F. Preparation, characterization and evaluation of flavonolignan silymarin effervescent floating matrix tablets for enhanced oral bioavailability. Molecules. 2023 Mar 13;28(6):2606.

Ahad HA, Kumar CS, Yesupadam P, Harika B, Deepika D, Leela LV, Chandra SA. Formulation and evaluation of once-daily sustained release aceclofenac prosophis juliflora gum matrix tablets. Int. J. Pharm. Sci. Rev. Res. 2010;1:23-8.

Ahad HA, Sreenivasulu R, Mallapu Rani E, Reddy BV. Preparation and evaluation of famotidine high density gastro retentive microspheres with synthetic and natural polymers. Journal of Pharmaceutical Education & Research. 2011 Jun 1;2(1).

Masuda H, Yoshida H, Iinoya K. Statistical analysis of carr's flowability index. Journal of the Research Association of Powder Technology, Japan. 1975 Apr 1;12(4):209-16.

Sandler N, Wilson D. Prediction of granule packing and flow behavior based on particle size and shape analysis. Journal of pharmaceutical sciences. 2010 Feb 1;99(2):958-68.

Ramya C. Novel approach in ranitidine hydrochloride effervescent oral floating technique. Journal of Pharmacy Research. 2011;4(1):104-106.

Krishna LV, Chandra PJ, Ragataragini T, et al. Formulation and evaluation of floating drug delivery system of enalapril maleate. International Journal of Tresnds in Pharmacy and Life Sciences. 2016;2(2):801-812.

Abdul Ahad H, Chinthaginjala H, Roja Y, Swathi K, Shravya P, Rashi A. A Tablet Matrix with Hibiscus rosa Sinensis Leave Mucilage for Effective Treatment of Rare Lymphangioleiomyomatosis Using Sirolimus. Trends in Pharmaceutical Sciences. 2022;8(1):43-50.

Annepogu H, Ahad HA, Nayakanti D. Determining the best poloxamer carrier for thiocolchicoside solid dispersions. Turkish Journal of Pharmaceutical Sciences. 2020;17(4):372. doi: 10.4274/tjps.galenos.2019.78800.

El-Menshawe SF, Ali AA, Halawa AA, Srag El-Din AS. A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization. Drug design, development and therapy. 2017:3377-3388. doi: 10.2147/DDDT.S144652.

Shamma RN, Basalious EB, Shoukri R. Development of novel sustained release matrix pellets of betahistine dihydrochloride: effect of lipophilic surfactants and co-surfactants. Pharmaceutical development and technology. 2012;17(5):583-593. doi: 10.3109/10837450.2011.557730.

Bouassida M, Manigniavy SA, Azaiez D, Bouassida Y. New approach for characterization and mitigation of the swelling phenomenon. Frontiers in Built Environment. 2022;8:836277.

Dixit N. Floating drug delivery system. Journal of current pharmaceutical research. 2011;7(1):6-20.

Wathore SA. Development and In-Vitro Evaluation of Betahistine Hydrochloride microspheres by Emulsification Solvent Evaporation Method. Asian Journal of Pharmaceutical Research and Development. 2019;7(5):30-36.

Al-Tamimi DJ, Ammoo AM, Alani ME, Ibraheem JJ. Pharmacokinetics and dose proportionality of betahistine in healthy individuals. Scientia Pharmaceutica. 2020;88(1):13.

Javed S, Hussain A, Shah PA, et al. Simultaneous quantification of sumatriptan succinate and prochlorperazine maleate in orodispersible films using two validated UV-spectroscopic methods. Pakistan Journal of Pharmaceutical Sciences. 2022;35.

Muñoz G, Valencia C, Valderruten N, Ruiz-Durántez E, Zuluaga F. Extraction of chitosan from Aspergillus niger mycelium and synthesis of hydrogels for controlled release of betahistine. Reactive and Functional Polymers. 2015;91:1-10.

Pilicheva B, Katsarov P, Kassarova M. Flowability evaluation of dry powder inhalation formulations intended for nasal delivery of Betahistine Dihydrochloride. Sikk Manipal Univ Med J. 2014;2(1):77-90.

Ahad HA, Sreeramulu J, Bindu VH, Reddy YP. Formulation and evaluation of Aloe barbadensis Miller mucilage based controlled release matrix tablets of glimepiride. Asian Journal of Chemistry. 2009;21(8):6271-6276.

Ahad HA, Chinthaginjala H, Meharajunnisa B, Vandana N, Gudisipalli R, Nikhila P. Past Work Done on the Matrix Tablets: A Quick Reference for the Research Beginner in Sustained-release Dosage Forms. International Journal of Pharmaceutical Investigation. 2023;13(3).

Ahad HA, Ravoori S, Budideti KKR, More S, Guddeti S, Patil VKR. Fabrication and in vitro evaluation of gliquidone matrix tablets with Abelmoschus esculentus fruit mucilage and povidone combination. ACTA Pharmaceutica Sciencia. 2011;53(1).

Suksaeree J, Monton C, Charoenchai L, Chankana N, Wunnakup T. Optimization of process and formulation variables for semha–pinas extract effervescent tablets using the box–behnken design. AAPS PharmSciTech. 2023;24(1):52. doi: 10.1208/s12249-023-02514-x.

El-Nabarawi MA, Ali AA, Aboud HM, Hassan AH, Godah AH. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. Drug design, development and therapy. 2016:4031-4045. doi: 10.2147/DDDT.S120613.

Shang R, Liu C, Quan P, Zhao H, Fang L. Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction. International journal of pharmaceutics. 2018;545(1-2):163-169. doi: 10.1016/j.ijpharm.2018.05.004.

Yu J, Xie J, Xie H, et al. Strategies for taste masking of orodispersible dosage forms: Time, concentration, and perception. Molecular Pharmaceutics. 2022;19(9):3007-3025. doi: 10.1021/acs.molpharmaceut.2c00199.

Blynskaya EV, Tishkov SV, Vinogradov VP, Alekseev KV, Marakhova AI, Vetcher AA. Polymeric Excipients in the Technology of Floating Drug Delivery Systems. Pharmaceutics. 2022;14(12):2779. doi: 10.3390/pharmaceutics14122779.

Kumar DJ, Ahad HA, Anuradha C, Kumar CS, Reddy B, Savithri R. Dual acting oral floating matrix tablets of ranitidine hydrochloride. 2010.

Abdul Ahad H, Sreeramulu J, Padmaja BS, Reddy MN, Prakash PG. Preparation of Fluconazole International Scholarly Research Notices. 2011;2011.

Published

2024-07-03

How to Cite

Kumar, P. ., PG, S. ., Abdul Ahad, H., Dhamala, P. ., D, S. ., & Sequeira, C. . (2024). Innovative Formulation and Evaluation of Betahistine Floating Tablets for Vertigo Management: Pharmaceutical sciences- Pharmaceutics. International Journal of Life Science and Pharma Research, 14(3), P1-P14. https://doi.org/10.22376/ijlpr.2024.14.3.P1-P14

Issue

Section

Research Articles